{
  "paper_metadata": {
    "pmid": "29093439",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data from the study of metastatic breast cancer."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1493del",
      "protein_notation": "p.E498fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, age not specified",
        "phenotype": "metastatic breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Patient #1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer with loss of heterozygosity of the BRCA2 mutation",
          "evidence_sentence": "Truncal mutations (defined as mutations present in all subclones and timepoints) in patient #1 included loss of heterozygosity of the patient\u2019s germline BRCA2 E1493fs mutation."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 mutation is associated with loss of heterozygosity, indicating a potential loss of function.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was noted in the context of a truncal mutation in a patient with metastatic breast cancer.",
      "key_quotes": [
        "loss of heterozygosity of the patient\u2019s germline BRCA2 E1493fs mutation"
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.49del",
      "protein_notation": "p.E17*",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, age not specified",
        "phenotype": "metastatic breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Patient #2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer with loss of heterozygosity of the BRCA2 mutation",
          "evidence_sentence": "Patient #2 possessed a germline heterozygous BRCA2 E49* mutation that underwent loss of heterozygosity in the patient\u2019s cancer."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 mutation is associated with loss of heterozygosity, indicating a potential loss of function.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was noted in the context of a truncal mutation in a patient with metastatic breast cancer.",
      "key_quotes": [
        "germline heterozygous BRCA2 E49* mutation that underwent loss of heterozygosity"
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2620del",
      "protein_notation": "p.V874fs",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, age not specified",
        "phenotype": "metastatic breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Patient #4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "metastatic breast cancer with a BRCA2 reversion mutation",
          "evidence_sentence": "This patient possessed a germline BRCA2 inactivating (V643fs) mutation, and relatively few truncal mutations."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 mutation is associated with loss of heterozygosity, indicating a potential loss of function.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was noted in the context of a truncal mutation in a patient with metastatic breast cancer.",
      "key_quotes": [
        "germline BRCA2 inactivating (V643fs) mutation"
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 3,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All extracted variants were confirmed to be in the BRCA2 gene."
  }
}